EPIDEMIOLOGY STUDY OF NPC PATIENTS IN BANGLI HOSPITAL AT 2015-2017
Keywords:NPC, stage, histopathology
Nasopharyngeal carcinoma (NPC) is a malignancy of the nasopharyngeal epithelium. Nasopharyngeal carcinoma is the five positions among other malignancies.
To determine the distribution of patients with nasopharyngeal cancer (NPC) in department of ENT Bangli hospital, the period during January 2015-December 2017.
Material and methods:
This descriptive study by collecting data from the medical record of NPC patients who come to the outpatient's clinic ENT Bangli hospital and data from the Department of Pathologic Anatomy at Bangli hospital.
The distribution patients with NPC was conducted from January 2015 until December 2017 there were 169 people. This research obtained the highest patients with NPC in 2016 as 67 cases. NPC based on sex in 2015 is males as 27 cases (58.70%), in 2016 is males as 43 cases (64.18%) and 2017 is males as 36 cases (64.29%). NPC based on age group is 41-50 years that in 2015 as 16 cases (34.70%), in 2016 as 27 cases (40.30%) and by age group 51-60 years in 2017 as 23 cases (41.07%). NPC patients based on stage most in stage III in 2015 as 18 cases (39.13%), in 2016 as 24 cases (35.82%) and in 2017 as 16 cases (28.57 %). NPC patients based on sex was found in stage III were males in 2015 as 14 cases, in 2016 as 16 cases and 2017 as 12 cases. NPC patients based on histopathology result at most on the WHO-3 classification, in 2015 as 44 (95.65%), in 2016 as 62 cases (92.54%) and in 2017 as 53 cases (94.64%).
Distribution of patients with NPC in Bangli hospital from January 2015 until the highest December 2017 were 169 people. This research obtained the highest population of NPC in 2016 as 67 cases. NPC based on sex in 2016 is male as 64.18%. NPC most found by age group in 41-50 years in 2016 as 40.30%. NPC based on stage most found in stage III, in 2016 as 35.82%. NPC based on sex most found in stage III in 2016 as 16 cases. NPC based on histopathology result is WHO-3 in 2016 as 92.54%.
 Jeyakumar A, Brickman TM, Jeyakumar A, Doerr T. Review of nasopharyngeal carcinoma. Ear, nose, throat journal. 2006;85(3):168-84.
 PERHATI-KL OSG-HNS. Demographic Research Proposal Nasopharyngeal Carcinoma in Indonesia. 2014:1-9.
 Green F, Page D, Fleming I, Fritz A, Balch C, Haller D, et al. American Joint Committee on Cancer. 2006.
 Jeyakumar A, Brickman TM, Jeyakumar A, Doerr TJE, nose, journal t. Review of nasopharyngeal carcinoma. 2006;85(3):168-84.
 Chan A, Felip E, Group EGW. Nasopharyngeal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Annals of Oncology. 2009;20(suppl_4):iv123-iv5.
 Zeng M-S, Zeng Y-X. Pathogenesis and etiology of nasopharyngeal carcinoma. Nasopharyngeal Cancer: Springer; 2010. p. 9-25.
 H K. Management Nasopharyngeal Carcinoma towards combination therapy/chemotherapy radiotherapy.
 Asroel HA. Radiotherapy In Nasopharyngeal Carcinoma Management. 2002.
 Lutan R, YU N, editors. Karsinoma nasofaring. Program dan abstrak pertemuan ilmiah tahunan Seminar Kanker Nasofaring Medan; 2001.
 Indonesia RACAoP. Cancer histopathological data Indonesia in 2003. Indonesian Cancer Foundation Directorate General of Medical Services MOH. 2003.
 Digby KH. Nasopharyngeal Carcinoma: Otolaryngology Lecture delivered at the Royal College of Surgeons of England under the auspices of the Institute of Laryngology and Otology* on 5th July, 1951. Annals of the Royal College of Surgeons of England. 1951;9(4):253.
 Yenita AA. Retrospective Study of Nasopharyngeal Carcinoma In West Sumatera: Reevaluation Subtype Histopathology Based on the WHO classification.
 Melani W. Karakteristik Penderita Kanker Nasofaring di Rumah Sakit H. Adam Malik Medan Tahun 2011. e-jurnal Fakultas Kedokteran USU. 2013;1(1).
 Society AC. Nasopharyngeal Cancer. 2014.
 Annisa R. Hemoglobin levels relationship with tumor responses in patients with cervical cancer who receive radiation therapy at Dr dr.Sardjito. 2013:1-43.
How to Cite
The Authors submitting a manuscript do so on the understanding that if accepted for publication, copyright of the article shall be assigned to The International Journal of Nasopharyngeal Carcinoma (IJNPC) as well as TALENTA Publisher Universitas Sumatera Utara as publisher of the journal.
Copyright encompasses exclusive rights to reproduce and deliver the article in all form and media. The reproduction of any part of this journal, its storage in databases and its transmission by any form or media, will be allowed only with a written permission from The International Journal of Nasopharyngeal Carcinoma (IJNPC).